• Product name

    Anti-ERAB antibody [5F3]
    See all ERAB primary antibodies
  • Description

    Mouse monoclonal [5F3] to ERAB
  • Host species

  • Specificity

    This antibody detects the recombinant human ERAB protein (27kDa) and recognizes the endogenous ERAB protein in cell extracts with virtually no crossreactivity with other human proteins.
  • Tested applications

    Suitable for: WB, Dot blot, IHC-P, IHC-Fr, ELISA, ICC/IFmore details
  • Species reactivity

    Reacts with: Human
  • Immunogen

    Recombinant, full-length Human ERAB protein (fusion protein).



Our Abpromise guarantee covers the use of ab10260 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/10000. Predicted molecular weight: 27 kDa.
Dot blot 1/100 - 1/10000.
IHC-P 1/100 - 1/1000.
IHC-Fr 1/100 - 1/1000.
ELISA Use at an assay dependent concentration.
ICC/IF 1/2000. PubMed: 17322883


  • Function

    Functions in mitochondrial tRNA maturation. Part of mitochondrial ribonuclease P, an enzyme composed of MRPP1/RG9MTD1, MRPP2/HSD17B10 and MRPP3/KIAA0391, which cleaves tRNA molecules in their 5'-ends. By interacting with intracellular amyloid-beta, it may contribute to the neuronal dysfunction associated with Alzheimer disease (AD).
  • Tissue specificity

    Expressed in normal tissues but is overexpressed in neurons affected in AD.
  • Involvement in disease

    Defects in HSD17B10 are the cause of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (MHBD deficiency) [MIM:300438]. MHBD deficiency leads to neurological abnormalities, including psychomotor retardation, and, in virtually all patients, loss of mental and motor skills.
    Defects in HSD17B10 are the cause of mental retardation syndromic X-linked type 10 (MRXS10) [MIM:300220]. MRXS10 is characterized by mild mental retardation, choreoathetosis and abnormal behavior.
    A chromosomal microduplication involving HSD17B10 and HUWE1 is the cause of mental retardation X-linked type 17 (MRX17) [MIM:300705]; also known as mental retardation X-linked type 31 (MRX31). Mental retardation is characterized by significantly sub-average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. In contrast to syndromic or specific X-linked mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation.
  • Sequence similarities

    Belongs to the short-chain dehydrogenases/reductases (SDR) family.
  • Cellular localization

  • Information by UniProt
  • Database links

  • Alternative names

    • 17 beta hydroxysteroid dehydrogenase 10 antibody
    • 17 beta hydroxysteroid dehydrogenase type 10 antibody
    • 17-beta-HSD 10 antibody
    • 17-beta-hydroxysteroid dehydrogenase 10 antibody
    • 17b HSD10 antibody
    • 3 hydroxy 2 methylbutyryl CoA dehydrogenase antibody
    • 3 hydroxyacyl CoA dehydrogenase type 2 antibody
    • 3 hydroxyacyl CoA dehydrogenase type II antibody
    • 3-hydroxy-2-methylbutyryl-CoA dehydrogenase antibody
    • 3-hydroxyacyl-CoA dehydrogenase type II antibody
    • 3-hydroxyacyl-CoA dehydrogenase type-2 antibody
    • AB binding alcohol dehydrogenase antibody
    • ABAD antibody
    • Ads9 antibody
    • Amyloid beta binding polypeptide antibody
    • Amyloid beta peptide binding alcohol dehydrogenase antibody
    • Amyloid beta peptide binding protein antibody
    • Amyloid beta peptide binding protein antibody
    • CAMR antibody
    • DUPXp11.22 antibody
    • Endoplasmic Reticulum Amyloid Binding Protein antibody
    • Endoplasmic reticulum associated amyloid beta peptide binding protein antibody
    • Endoplasmic reticulum-associated amyloid beta-peptide-binding protein antibody
    • ER associated amyloid beta-binding protein antibody
    • ERAB antibody
    • HADH 2 antibody
    • HADH2 antibody
    • HCD 2 antibody
    • HCD2 antibody
    • HCD2_HUMAN antibody
    • Hsd17b10 antibody
    • Hydroxyacyl CoA Dehydrogenase type II antibody
    • Hydroxyacyl Coenzyme A dehydrogenase type II antibody
    • Hydroxysteroid (17 beta) dehydrogenase 10 antibody
    • Mental retardation X linked syndromic 11 antibody
    • MHBD antibody
    • Mitochondrial L3 Hydroxyacyl CoA Dehydrogenase antibody
    • Mitochondrial ribonuclease P protein 2 antibody
    • Mitochondrial RNase P protein 2 antibody
    • MRPP2 antibody
    • MRX17 antibody
    • SCHAD antibody
    • SDR5C1 antibody
    • Short chain dehydrogenase/reductase family 5C member 1 antibody
    • Short chain L 3 hydroxyacyl CoA dehydrogenase type 2 antibody
    • Short chain type dehydrogenase/reductase XH98G2 antibody
    • Short-chain type dehydrogenase/reductase XH98G2 antibody
    • Type 10 17b HSD antibody
    • Type 10 17beta hydroxysteroid dehydrogenase antibody
    • Type II HADH antibody
    • XH98G2 antibody
    see all


  • IHC staining of purifiedab10260 on formalin-fixed paraffin-embedded human colon tissue. The tissue was incubated with 10 µg/ml of the primary antibody for 60 minutes at room temperature. A HRP kit was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm

  • IF using ab10260.


This product has been referenced in:

  • Bertolin G  et al. The TOMM machinery is a molecular switch in PINK1 and PARK2/PARKIN-dependent mitochondrial clearance. Autophagy 9:1801-17 (2013). ICC/IF ; Human . Read more (PubMed: 24149440) »
  • Kitchens CA  et al. Identification of chemosensitivity nodes for vinblastine through small interfering RNA high-throughput screens. J Pharmacol Exp Ther 339:851-8 (2011). Human . Read more (PubMed: 21880871) »
See all 4 Publications for this product

Customer reviews and Q&As

1-6 of 6 Abreviews or Q&A


Thank you for your email. Unfortunately, we do not know the exact epitope that this product recognizes. We have not done an epitope mapping project for this yet. I apologize for the inconvenience.

Read More


The application was added to the datasheet based on publication in the following reference:

Stevanin G et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 39:366-372 (2007) (PubMed: 17322883).

The antibody was also used in the following reference, for IF (Figure 2) as well as western blotting.

Onoguchi K et al. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 6:e1001012 (2010). (PubMed: 20661427).

The protocol in the paper is as follows:

For immunofluorescence analysis, cells were fixed with 4% paraformaldehyde for 10 min, permeabilized with an acetone: methanol (11) solution, and blocked with 5mg/ml of BSA in PBST (PBS, 0.04% Tween20) for 1 hour. The cells were next incubated with relevant primary antibodies overnight at 4°C, and then incubated with relevant Alexa Fluor 405, Alexa Fluor 488, or Alexa Fluor 594-conjugated secondary antibodies.

We are not aware of any data from staining of monkey samples.

Read More


Thank you for your enquiry. I am sorry that unfortunately, we are unable to supply this anti-ERAB antibody (ab10260) without sodium azide. We do, however, have another anti-ERAB antibody available that contains no preservatives. This is a Mouse monoclonal [10D12] to ERAB, ab17298. Please be aware that non of these antibodies have been tested for your in vivo application. I hope this helps. Please don't hesitate to get back to me if you have any further questions.

Read More


Thank you for your email. ERAB is identical to SCHAD. The following reference that I found explains this best: Characterization and localization of human type10 17-hydroxysteroid dehydrogenase; Eur. J. Biochem. 268, 4899-4907 (2001). In it the authors state "Human short chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) is encoded by the SCHAD gene [10]. Human SCHAD is a member of the SDR family [17] but not the L-3-hydroxyacyl-CoA dehydrogenase (HAD) family [34], because it does not have a signature sequence that defines this family [27,35]. The use of term SCHAD to refer to members of the HAD family has been discouraged because it is inaccurate [36]. It exhibits oxidative 17/3-hydroxysteroid dehydrogenase activities toward sex steroids [11], which leads us to designate this 108-kDa protein as 17-HSD type 10. Because this protein exhibits a high affinity for A peptide and was reported to be associated with the ER, it had been referred to as ER-associated A binding protein (ERAB) [18], and was thought to be a putative A receptor. However, we found that SCHAD is present in mitochondria [11,19]. If this protein is specifically targeted to mitochondria, it seems unlikely that it could readily bind A generated in the ER as had been postulated previously." If you have any additional questions, please contact us again.

Read More


Unfortunately, we do not have more information about this antibody. We will update the on-line datasheet of this product as soon as we get more data. We apologize for any inconvenience caused.

Read More


Unfortunately, we do not have more information about this antibody. We will update the on-line datasheet of this product as soon as we get more data. We apologize for any inconvenience caused. If you have any more questions, please do contact us again.

Read More

For licensing inquiries, please contact partnerships@abcam.com

Sign up